NCT01858532View on ClinicalTrials.gov

Study Of Diabetic Nephropathy With Atrasentan

PHASE3TerminatedINTERVENTIONAL
Enrollment

5,107

Participants

Timeline

Start Date

May 17, 2013

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions
Diabetic Nephropathy
Interventions
DRUG

Atrasentan

Film-coated tablet

DRUG

Placebo

Film-coated tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY